Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 16 of 16 for “"TMP/SMX"”.

  1. A retrospective study to evaluate the efficacy of trimethoprim/sulfamethoxazole (TMP/SMX) compared to daptomycin or linezolid for the treatment of infections due to methicillin-resistant <i>staphylococcus aureus</i> (MRSA)

    … drugs, and trimethoprim/sulfamethoxazole(TMP/SMX), an old, inexpensive agent. Study aims were to compare the clinical efficacy and potential cost savings associated with TMP/SMX use. Methods: A retrospective study was conducted at Detroit Medical Center. For calendar year 2009, unique …

    emich Repository record for A retrospective study to evaluate the efficacy of trimethoprim/sulfamethoxazole (TMP/SMX) compared to daptomycin or linezolid for the treatment of infections due to methicillin-resistant <i>staphylococcus aureus</i> (MRSA) (opens in a new tab)

  2. "TWENTY YEARS OF KNOWLEDGE ABOUT PCP SEEMED TO GET SWEPT AWAY":CONTESTED THERAPIES IN THE AIDS EPIDEMIC

    … Two drugs, trimethoprim-sulfamethoxazole (TMP-SMX) and pentamidine, were shown to be highly effective for its treatment and prevention. In the1980's PCP appeared abruptly in urban gay men, a harbinger of the AIDS epidemic and its leading direct cause of death. Using sources in the medical …

    jhu Repository record for "TWENTY YEARS OF KNOWLEDGE ABOUT PCP SEEMED TO GET SWEPT AWAY":CONTESTED THERAPIES IN THE AIDS EPIDEMIC (opens in a new tab) Embargoed until 2026-12-01

  3. Whole Genomes of Trimethoprim Resistant 'Escherichia coli' Isolates from Urinary Tract Infections in New Zealand

    … species (Zhang et al., 2019). Trimethoprim (TMP) is a synthetic folic acid antibiotic which was commonly used as a first-line treatment for UTIs and is now used in combination with sulfamethoxazole (SMX) as TMP-SMX. However, current global TMP prescription rates have declined due to the high …

    auckland-tech Repository record for Whole Genomes of Trimethoprim Resistant 'Escherichia coli' Isolates from Urinary Tract Infections in New Zealand (opens in a new tab)

  4. Resistenzsituation von E. coli bei ambulant erworbener unkomplizierter Harnwegsinfektion (SARHA-Studie 2016) unter Nutzung der Strukturen der Antibiotika-Resistenz-Surveillance (ARS)

    … Verursacher einer HWI – gegenüber Trimethoprim (TMP) und Cotrimoxazol (TMP-SMX) sowie weiteren Antibiotika bei ambulant erworbenen HWI, um zu untersuchen, ob diese bei der kalkulierten Therapie einsetzbar sind. Anhand des Vergleiches der in der Studie ermittelten Resistenzanteile mit denen der …

    fu-berlin Repository record for Resistenzsituation von E. coli bei ambulant erworbener unkomplizierter Harnwegsinfektion (SARHA-Studie 2016) unter Nutzung der Strukturen der Antibiotika-Resistenz-Surveillance (ARS) (opens in a new tab)

  5. Stenotrophomonas maltophilia induzierte Endophthalmitis

    … of therapy to trimethoprim/sulfamethoxazol (TMP-SMX) 960mg bid i.v. and Ciprofloxacin 400mg -750mg bid p.o. for 10 days and TMP-SMX 960mg bid p.o. and Ciprofloxacin 250mg or 500mg bid p.o. for further 20 days, complemented with i.v. Fluorcortolone and topical treatment. Vision was examined …

    lmu-germany Repository record for Stenotrophomonas maltophilia induzierte Endophthalmitis (opens in a new tab)

  6. Σύγκριση βραχέων θεραπευτικών σχημάτων για την θεραπεία του κατώτερου ουροποιητικού σε γυναίκες

    … is, as safe and effective as, a 3 day course of TMP-SMX, for the treatment of uncomplicated lower UTI’s in women. According to the results of our retrospective study, the most important driver leading to failure of prophylaxis for recurrent lower UTI’s, is the lack of compliance of women with the …

    greece Repository record for Σύγκριση βραχέων θεραπευτικών σχημάτων για την θεραπεία του κατώτερου ουροποιητικού σε γυναίκες (opens in a new tab)

  7. NEONATAL IMMUNE MODULATION TO IMPROVE PNEUMOCYSTIS CLEARANCE

    … in pup mice; however, when combined with TMP/SMX it improves PC clearance and maintains a reduced PC burden following discontinuation of therapy. Furthermore, we have shown that GM-CSF improves the ability of human infant lung macrophages to phagocytose PC organsms without generating an …

    uky-thes Repository record for NEONATAL IMMUNE MODULATION TO IMPROVE PNEUMOCYSTIS CLEARANCE (opens in a new tab)

  8. Untersuchungen zum Abstoßungs- und Infektionsrisiko nach Nierentransplantation

    … die Rolle von Trimethoprim/Sulfamethoxazol (TMP/SMX) als Erstlinien-Therapie bei Hinweisen auf eine höhere Effektivität. Dennoch kann auf Basis unserer Daten C-P als Alternative zu TMP/SMX im Falle von schweren Nebenwirkungen oder Allergien unter dieser Therapie erwogen werden.

    fu-berlin Repository record for Untersuchungen zum Abstoßungs- und Infektionsrisiko nach Nierentransplantation (opens in a new tab)

  9. Φαρμακευτικές αντιδράσεις σε HIV ασθενείς

    … attributed mostly to the administration of TMP-SMX, whereas NVP was the major causative agent for those observed during the second peak period. Lipodystrophy and maculopapular drug reactions attributed to NVP and other ART medications were mostly observed during the second ART period. …

    greece Repository record for Φαρμακευτικές αντιδράσεις σε HIV ασθενείς (opens in a new tab)

  10. IN VITRO HEPATIC OXIDATIVE BIOTRANSFORMATION OF TRIMETHOPRIM

    Introduction: Trimethoprim-sulfamethoxazole (TMP-SMX) is a commonly used antibiotic often associated with idiosyncratic adverse drug reactions (IADRs). Historically, bioactivation of SMX to a reactive intermediate has been implicated in IADRs. Recently, the bioactivation of TMP has been described …

    ku Repository record for IN VITRO HEPATIC OXIDATIVE BIOTRANSFORMATION OF TRIMETHOPRIM (opens in a new tab)

  11. Design and Synthesis of Pyrimidine Based Heterocycles as Potential Anti-cancer Agents with Combination Chemotherapeutic Potential or Targeted One Carbon Metabolism Inhibition and Anti-opportunistic Agents

    … therapies such as trimethoprim-sulfamethoxazole (TMP-SMX) combination, which has been used for PCP for decades, has major limitations due to low inhibitory potency of TMP, side-effects of SMX and emergence of resistant strains expressing mutated dihydropteroate synthase enzyme (target of SMX). For …

    duquesne Repository record for Design and Synthesis of Pyrimidine Based Heterocycles as Potential Anti-cancer Agents with Combination Chemotherapeutic Potential or Targeted One Carbon Metabolism Inhibition and Anti-opportunistic Agents (opens in a new tab)

  12. The Microbes Within: Pathogen In-Host Adaptation and the Gut Microbiome During Persistent Colonization and Recurrent Infection

    … rUTI risk, while change of antimicrobials and TMP-SMX were associated with decreased risk. I also found significant differences in gut microbiome composition between urinary tract colonized and non-colonized patients at post-antimicrobial days 7-14, marked by elevated E. coli abundance in …

    wustl Repository record for The Microbes Within: Pathogen In-Host Adaptation and the Gut Microbiome During Persistent Colonization and Recurrent Infection (opens in a new tab)

  13. Single Atom Catalysts on Biochar for the Removal of Organic Contaminants in Water

    … the first instance of direct oxidation of TMP by single-atom Zn catalyst on biochar. The study also identifies superoxide and hydroperoxyl radicals as the main reactive species for TMP oxidation. Overall, this study demonstrates a combined radical and nonradical way for TMP oxidation by …

    tamu Repository record for Single Atom Catalysts on Biochar for the Removal of Organic Contaminants in Water (opens in a new tab)

  14. Longitudinal Patterns of Antimicrobial Resistance in Escherichia coli Isolated from Children <5 Years of Age Following Hospital Discharge in Kenya and the Impact of a 5-Day Course of Azithromycin

    … (AMP) and trimethoprim-sulfamethoxazole (TMP/SMX) remained highest at the end of follow-up at month six (72% and 84%, respectively). Carriage of ESBL-producing E. coli dropped from 44% at hospital discharge to 11% at six months post-hospital discharge. There were no statistically …

    washington Repository record for Longitudinal Patterns of Antimicrobial Resistance in Escherichia coli Isolated from Children <5 Years of Age Following Hospital Discharge in Kenya and the Impact of a 5-Day Course of Azithromycin (opens in a new tab)

  15. Target Based Design and Synthesis of Fused Pyrimidines in the Potential Treatment of Cancer and Opportunistic Infection

    … in humans). Trimethoprim-sulfamethoxazole (TMP-SMX) combination, which has been used for PCP for decades, has major limitations due to low inhibitory potency of TMP, side-effects of SMX and emergence of resistant strains expressing mutated dihydropteroate synthase enzyme (target of SMX). For …

    duquesne Repository record for Target Based Design and Synthesis of Fused Pyrimidines in the Potential Treatment of Cancer and Opportunistic Infection (opens in a new tab)